INTS10 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the INTS10 protein, a component of the Integrator complex. The Integrator complex is involved in the processing of small nuclear RNAs (snRNAs) and plays a crucial role in RNA polymerase II-mediated transcription. INTS10, as a subunit of this complex, contributes to the regulation of transcriptional processes by coordinating the cleavage and processing of nascent RNA transcripts. The Integrator complex is particularly important for the maturation of snRNAs, which are essential for the splicing of pre-mRNA. INTS10 inhibitors are designed to disrupt the function of this specific subunit, thereby impacting the overall activity of the Integrator complex and the efficiency of snRNA processing and transcription regulation.
The design of INTS10 inhibitors focuses on targeting critical domains within the INTS10 protein that are necessary for its interaction with other subunits of the Integrator complex or its engagement with RNA polymerase II. These inhibitors may act by binding to the active site of INTS10 or by disrupting its ability to form stable complexes with other proteins, thus blocking its role in RNA processing. The interaction between INTS10 inhibitors and the protein typically involves non-covalent forces such as hydrogen bonding, van der Waals forces, and hydrophobic interactions, ensuring high specificity in targeting INTS10's functional regions. By inhibiting INTS10, researchers can investigate its precise role in transcription regulation and RNA processing, offering insights into how the Integrator complex governs gene expression and maintains RNA stability. These inhibitors are essential tools for studying the molecular mechanisms underlying RNA maturation and the broader implications of Integrator complex activity in cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA Polymerase II (Pol II)-driven transcription, potentially affecting snRNA processing. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits transcription elongation by Pol II, potentially impacting integrator complex functions. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Cyclin-dependent kinase inhibitor, affecting transcription regulation and potentially snRNA processing. | ||||||
RGFP966 | 1357389-11-7 | sc-507300 | 5 mg | $115.00 | ||
Selective inhibitor of histone deacetylase 3 (HDAC3), indirectly affecting transcription processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
HDAC inhibitor, could indirectly influence the processing of snRNAs and integrator complex activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Broad HDAC inhibitor, potentially affecting chromatin structure and transcription. | ||||||
CPI-203 | 1446144-04-2 | sc-501599 | 1 mg | $170.00 | ||
Inhibits CREB binding protein (CBP)/p300, potentially impacting transcription and snRNA processing. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomain proteins, indirectly influencing transcription processes. | ||||||
THZ1 | 1604810-83-4 | sc-507542 | 1 mg | $95.00 | ||
Covalent inhibitor of CDK7, affecting transcription initiation and elongation. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Inhibits the spliceosome, potentially impacting processes related to snRNA. | ||||||